Application developers and solution partners often need to process healthcare data outside of the electronic medical record (EMR) system. EMRs are primarily designed to directly support individual patient care, with…
Labcorp plans to offer Roche’s recently FDA-cleared blood test to assess early signs of Alzheimer’s disease and other causes of cognitive decline for patients 55 years and older. The blood…
Roche’s diagnostics business continues to be buffeted by China headwinds, but the Swiss major believes it has enough underlying sales strength to weather the storm. Roche’s diagnostics division grew by…
In one of the biggest healthcare acquisitions of its kind this year, medtech diagnostics specialist Hologic will go private following its sale to Blackstone and TPG in a deal valued…
Boston Scientific’s third-quarter revenue topped $5 billion, up 20.3% year over year. Growth eased slightly from the second quarter, when sales rose more than 22%. Urology led the gains, up…
Thermo Fisher Scientific’s plan for growth is paying off as the biopharma service provider and supplier posted a sales bump in the third quarter. The company, which has business lines…
Walmart will become the first U.S. retailer to sell Abbott’s continuous glucose monitoring device as the medtech giant looks to broaden its sales potential for its growing business unit. Abbott…
It is financial reporting season, and a few major medtech companies posted third-quarter sales growth. Quest Diagnostics and Danaher both reported year-over-year growth. The results follow the Trump administration’s late-September…
A retinal implant developed by Science Corp. has for the first time restored some functional vision to patients with a severe form of age-related macular degeneration (AMD), a common eye…
Boston Scientific shelled out $533 million to buy up the remaining equity it had in Nalu Medical, a private company that produces a miniaturized neurostimulation implant aimed at treating chronic…